States in which recreational cannabis is legal see declining codeine prescriptions; the FDA plans to simplify the use of COVID-19 vaccines; state-wide abortion debates ramp up as Congress deadlocks
Legal Recreational Cannabis Linked to Lower Demand for Codeine Prescriptions
New research suggests that legalizing the use of recreational cannabis is one way that may help curb the demand for codeine prescriptions, according to US News & World Report. A recent study found an overall reduction of 26% in pharmacy-based codeine distribution and up to a 37% reduction after recreational cannabis laws were inb effect for 4 years. Misuse of pharmacy-based distribution of codeine has accounted for more than 10,000 overdoses in the United States in recent years.
FDA Plans to Simplify and Update the Use of COVID-19 Vaccines
The FDA has announced that it wants to make the COVID-19 vaccine process more like the annual flu vaccine process, according to CNN Health. This could include changes such as streamlining the vaccine composition, immunization schedules, and periodic updates to the COVID-19 vaccine. Furthermore, the FDA announced that most people may only need 1 dose of the latest COVID-19 vaccine to restore protection against the virus.
Abortion Debates Intensify Across States as Congress Deadlocks
With deadlocks in Washington, DC, abortion debates are shifting to states convening their first legislative sessions since the overturn of Roe v Wade, according to Kaiser Health News. Anti-abortion groups say that their goal in overturning Roe v Wade was to bring the decision back to the states. However, they are now making it clear that they want a national abortion ban. Meanwhile, at the federal level, the Biden administration has made efforts to make mifepristone more accessible by allowing its distribution in pharmacies and through US mail.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Commonwealth Fund Report Details Pervasive Racial and Ethnic Disparities in US Health Care, Outcomes
April 18th 2024Using 25 health system performance indicators, the Commonwealth Fund 2024 State Health Disparities Report evaluated racial and ethnic disparities in health care and health outcomes both within and across US states and highlighted the urgent need for equitable health care policies and practices in the US.
Read More